Side effects in the LIBTAYO study

What are the possible side effects of LIBTAYO?

LIBTAYO can cause serious side effects. Click here to review “What is the most important safety information I should know about LIBTAYO?” The most common side effects of LIBTAYO include muscle or bone pain, tiredness, rash and diarrhea. These are not all the possible side effects of LIBTAYO. Call your doctor for medical advice about side effects.

In the LIBTAYO clinical trial* which included patients with locally advanced BCC previously treated with an HHI, the most common side effects were:

  • 65 out of 132 patients (49%)
    experienced tiredness

  • 44 out of 132 patients (33%)
    experienced muscle or bone pain

  • 33 out of 132 patients (25%)
    experienced diarrhea

  • 29 out of 132 patients (22%)
    experienced having a rash

  • 26 out of 132 patients (20%)
    experienced itching

  • 20 out of 132 patients (15%)
    experienced infection of the nose, throat, and/or airways

  • 19 out of 132 (14%)
    experienced a loss of appetite

  • 17 out of 132 patients (13%)
    experienced anemia
    (low red blood cell count)

  • 16 out of 132 patients (12%)
    experienced nausea

  • 16 out of 132 patients (12%)
    experienced a UTI
    (urinary tract infection)

  • 16 out of 132 patients (12%)
    experienced headaches

  • 15 out of 132 patients (11%)
    experienced constipation

  • 15 out of 132 patients (11%)
    experienced shortness of breath

  • 15 out of 132 patients (11%)
    experienced high blood pressure

*84 out of 132 patients in the trial had
locally advanced BCC.

Review examples of patient
responses to LIBTAYO
in clinical trials.

See the responses